A patient was seen with secondary cluster headache whose acute pain responded promptly to sumatriptan. The headaches started after injury to the vertebral artery. This finding provides clinical affirmation of the existence of the trigeminallcervical nuclear overlap that is central to this condition. (J Neurol Neurosurg Psychiatry 1995;59:633-634) Keywords: vertebral artery dissection; cluster headache; sumatriptan Cluster headache is a rare form of primary headache marked by unilateral excruciating pain in association with autonomic features.' It is unusual to see as a secondary phenomenon and in this setting its management is a considerable challenge. A case of secondary cluster headache is presented which has allowed the chance to examine the utility of sumatriptan in this clinical setting. tal nerve with local anaesthetic which left him pain free for several days. After the headaches returned he was treated with a C2 facet block which left him without headache for six months. The headaches subsequently recurred for another six months before being controlled by methysergide. For acute attacks, oxygen treatment often worked well if used early enough. Oral ergots were of no use. During the hospital admission, he was given sumatriptan (6 mg subcutaneously), which aborted the attack very rapidly, within minutes. This approach was used several times and on each occasion his headache responded rapidly to sumatriptan. He had no side effects aside from some irritation at the site of injection. We present a case of the uncommon condition of secondary episodic cluster headache. It has not been previously reported after vertebral artery dissection. The headaches show many typical features of cluster headache, including ipsilateral lacrimation, rhinorrhoea, and Homer's syndrome. The unilateral boring pain and the temporal spacing of attacks are also typical, as is the response to oxygen, and the initial response to methysergide. The duration of the pain is perhaps a little long and the patient is older than average for the usual idiopathic cluster headache.
Cluster headache is a rare form of primary headache marked by unilateral excruciating pain in association with autonomic features.' It is unusual to see as a secondary phenomenon and in this setting its management is a considerable challenge. A case of secondary cluster headache is presented which has allowed the chance to examine the utility of sumatriptan in this clinical setting. tal nerve with local anaesthetic which left him pain free for several days. After the headaches returned he was treated with a C2 facet block which left him without headache for six months. The headaches subsequently recurred for another six months before being controlled by methysergide. For acute attacks, oxygen treatment often worked well if used early enough. Oral ergots were of no use. During the hospital admission, he was given sumatriptan (6 mg subcutaneously), which aborted the attack very rapidly, within minutes. This approach was used several times and on each occasion his headache responded rapidly to sumatriptan. He had no side effects aside from some irritation at the site of injection. We present a case of the uncommon condition of secondary episodic cluster headache. It has not been previously reported after vertebral artery dissection. The headaches show many typical features of cluster headache, including ipsilateral lacrimation, rhinorrhoea, and Homer's syndrome. The unilateral boring pain and the temporal spacing of attacks are also typical, as is the response to oxygen, and the initial response to methysergide. The duration of the pain is perhaps a little long and the patient is older than average for the usual idiopathic cluster headache.
There have been only a few reports of secondary cluster headache. In a series of 11 patients, Matthew and Rueveni noted that most cases followed facial trauma with soft tissue injury.3 In all but one patient, injuries occurred in the trigeminal territory. Although the attacks looked like cluster headache, with ipsilateral autonomic features, they did not show the usual periodicity or remissions and were refractory to treatment. Cluster headaches have also been reported with an arteriovenous malformation in the occipital lobe,4 pituitary adenoma,5 and upper cervical meningioma.6 Of particular interest in regard to our case is a report of a 55 year old man with a 12 year history of cluster headache on the right side associated with an ipsilateral vertebral artery aneurysm.7 The headaches resolved when the aneurysm was clipped. The authors postulated that the aneurysm irritated the Cl and C2 fibres that innervate the dura mater. Koenigsberg et a18 reported cluster headaches developing in association with a pseudoaneurysm of the intracavernous carotid artery. Their patient supports the generally held view that the cavernous sinus is a key locus of pathology in cluster headaches, with a convergence of fibres from the first two divisions of the trigeminal nerve as well as both sympathetic and parasympathetic fibres. The patient presented here suggests a more complex central mechanism for the initiation of attacks.
RESPONSE TO SUMATRIPTAN
The patient in this study responded promptly to sumatriptan. To our knowledge sumatriptan has not been previously used in secondary cluster headache. Sumatriptan is a 5-hydroxytryptamine (5HTID) receptor agonist, which has been shown to be effective in randomised, double blind, placebo controlled trials in patients with primary cluster headache. 
